Versant Capital Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$183K Sell
12,093
-3,173
-21% -$48K 0.02% 660
2026
Q1
$166K Buy
15,266
+10,200
+201% +$127K 0.02% 656
2025
Q4
$65.5K Buy
5,066
+1,444
+40% +$18.5K 0.01% 949
2025
Q3
$46.8K Sell
3,622
-13,637
-79% -$182K 0.01% 1077
2025
Q2
$307K Buy
17,259
+3,560
+26% +$62K 0.05% 312
2025
Q1
$244K Buy
13,699
+10,358
+310% +$235K 0.04% 356
2024
Q4
$99.6K Buy
3,341
+880
+36% +$18.6K 0.02% 316
2024
Q3
$38.5K Sell
2,461
-556
-18% -$10.1K 0.01% 549
2024
Q2
$51.7K Buy
3,017
+2,917
+2,917% +$51.3K 0.01% 366
2024
Q1
$1.56K Buy
+100
New +$1.47K ﹤0.01% 1427
2023
Q4
Sell
-35
Closed -$565 1981
2023
Q3
$565 Buy
35
+33
+1,650% +$951 ﹤0.01% 1668
2023
Q2
$83 Sell
2
-4
-67% -$248 ﹤0.01% 2034
2023
Q1
$361 Hold
6
﹤0.01% 1634
2022
Q4
$440 Hold
6
﹤0.01% 1448
2022
Q3
$0 Hold
6
﹤0.01% 1577
2022
Q2
$0 Hold
6
﹤0.01% 1577
2022
Q1
$0 Sell
6
-2
-25% -$147 ﹤0.01% 1573
2021
Q4
$1K Hold
8
﹤0.01% 1315
2021
Q3
$1K Buy
8
+2
+33% +$302 ﹤0.01% 1329
2021
Q2
$1K Hold
6
﹤0.01% 1331
2021
Q1
$1K Hold
6
﹤0.01% 1404
2020
Q4
$1K Hold
6
﹤0.01% 1238
2020
Q3
$0 Hold
6
﹤0.01% 1437
2020
Q2
$0 Hold
6
﹤0.01% 1478
2020
Q1
$0 Hold
6
﹤0.01% 1565
2019
Q4
$0 Hold
6
﹤0.01% 1513
2019
Q3
$0 Hold
6
﹤0.01% 1523
2019
Q2
$0 Buy
+6
New +$304 ﹤0.01% 1611

Other funds holding NVCR